Atlas Trials

High Risk for Febrile Neutropenia of Chemotherapy Regimens

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High Risk for Febrile Neutropenia of Chemotherapy Regimens

RecordFirmDate
Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN (NCT07187908)Henan Cancer Hospital2025-01-01

Track High Risk for Febrile Neutropenia of Chemotherapy Regimens automatically

Every clearance here is in the API, with alerts when new ones post.